Navigation Links
Aethlon Medical Announces Washington, DC Shareholder Presentation
Date:12/20/2010

ral load reduction at the outset of standard of care drug regimens.  
  • Human Immunodeficiency Virus (HIV):  Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
  • Bioterror and Pandemic Threats:  Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.

  • The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.

    In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.

    Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discove
    '/>"/>

    SOURCE Aethlon Medical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board
    2. Aethlon Medical to Present at LD MICRO Conference on December 3, 2009
    3. Aethlon Medical, Inc. Announces Annual Meeting Results
    4. Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates
    5. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
    6. Medical science helps UK athletes reach peak performance
    7. Rush-Copley Medical Center Selects Pharmacy Xpert from Thomson Reuters to Improve Medication Management
    8. Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely
    9. Integrated Medical Systems Technology Recognized as Qualified Therapeutic Discovery
    10. Wound Management Technologies to Present at LifeTech Capital Miami Medical Investors Conference
    11. Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage Biotech ... PBT.U), and Biohaven Pharmaceutical Holding Company Limited (Biohaven), ... Phase I study of BHV-0223, a glutamate modulating ... regarding BHV-0223 and recently obtained clearance from the ... with human testing. Portage holds 54% equity interest ...
    (Date:8/27/2015)... Calif. , Aug. 27, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... conferences in the month of September.  ... present at Rodman & Renshaw,s 17th Annual Global Investment ... PT at the St. Regis Hotel in ...
    (Date:8/27/2015)... Aug. 27, 2015 HUYA Bioscience International (HUYA) today ... the Japan Society of HTLV-1, held this week at ... purpose of the Society is to promote research on ... of medical technology and research related to these fields ... "HUYA is proud to support this prestigious conference," ...
    (Date:8/27/2015)... ... 27, 2015 , ... Inc. Magazine released its annual list of the 5,000 ... in growth for the three years through 2014. Being named to the Inc. 5000 ... in the country. , “We are thrilled to make the Inc. 5000 list ...
    Breaking Biology Technology:Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3
    ... MADISON, N.J., March 12 Wyeth (NYSE: ... the SG Cowen & Co. 29th Annual Healthcare Conference ... Time. Presenting for Wyeth will be Mikael Dolsten, ... Wyeth.Wyeth,s presentation will be webcast live for investors at ...
    ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... the treatment of cardiovascular and metabolic disease, today announced ... purchase agreement (together with certain ancillary agreements, the "Loan ... one of its affiliates (collectively, "Lender"), the Company,s principal ...
    ... utilizing pET vectors for bacterial expression has been the ... patented. In order to tackle this problem, DNA2.0 has ... are free of IP constraints. pJexpress vectors are specifically ... been shown to express better than comparable pET vectors. ...
    Cached Biology Technology:Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference 2VIA Pharmaceuticals Secures Financing Up to $10.0 Million 2VIA Pharmaceuticals Secures Financing Up to $10.0 Million 3VIA Pharmaceuticals Secures Financing Up to $10.0 Million 4DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 2DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 3
    (Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
    (Date:8/18/2015)... , Aug. 17, 2015 Research and ... of the "Global Biometric Authentication & Identification ... Estimation & Forecast, 2015-2020" report to their ... and identification systems market is expected to grow ... to 2020 and generate over $25 billion (approximately) ...
    (Date:8/12/2015)... JOSE, Calif. , Aug. 12, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... recently announced Match-in-Sensor solution, have officially been named ... Alliance. As part of the certification, Synaptics, Natural ... FIDO 1.0 Universal Authentication Framework (UAF) standard and ...
    Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
    ... the marine whelk, Solenosteira macrospira . He does all the ... though few of the baby snails are his own. The ... puts S. macrospira in a small club ... promiscuity and sibling cannibalism, and the species has one of the ...
    ... Researchers at Polytechnic Institute of New York University (NYU-Poly) ... smallest single virus particles in solution, an advance that ... and shrink test result wait times from weeks to ... physics and member of the Othmer-Jacobs Department of Chemical ...
    ... compound from the aminopyridine class not only has the potential ... of malaria, but might also be able to block transmission ... research collaboration involving the Medicines for Malaria Venture (MMV), based ... at the University of Cape Town, South Africa. On the ...
    Cached Biology News:Male snails babysit for other dads 2Male snails babysit for other dads 3By detecting smallest virus, researchers open possibilities for early disease detection 2By detecting smallest virus, researchers open possibilities for early disease detection 3African research identifies strong candidate for possible single-dose malaria cure 2African research identifies strong candidate for possible single-dose malaria cure 3
    sPLA2-XII Human, Rabbit Polyconal Antibody Anti-Human sPLA2-XII Antibody was raised in rabbits against Human sPLA2-XII His-Tagged Fusion Protein Antigen: The recombinant human protein sPLA-XII...
    ... computing power of your ValveBank system! Program ... PC computer running Windows 98, 2000, XP using ... to disk, print out program listings, then download ... simple step., EasyCode is used for programming before ...
    Porcine Aortic Smooth Muscle Cells (PAOSMC) (>500,000 cells)...
    Bovine Renal Artery Smooth Muscle Cells (BRASMC) (>500,000 cells)...
    Biology Products: